BMO Capital analyst Alex Arfaei said Pfizer's (NYSE: PFE) risk/reward in PFE remains favorable, but given the stock's strong performance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE